Apr 1, 2026 Log in

News

【Medigen Biotechnology】April 2026 Revenue: 0.02 Billion (Down 65.5% YoY)

Citation-Grade Primary-source linked Schema.org verified NQ 0 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Apr 1, 2026 9:00 AM ・ Updated Jun 13, 2026 8:26 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

This indicates a challenging period for the company in the biotech and medical sector.

Medigen Biotechnology (6794) reported April 2026 revenue of 18.94 million yuan, a significant decrease of 65.5% year-on-year. This indicates a challenging period for the company in the biotech and medical sector.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: Apr 1, 2026

Press Release Information Title: 【Medigen Biotechnology】April 2026 Revenue: 0.02 Billion (Down 65.5% YoY) Company Name: Medigen Biotechnology Industry: Biotechnology and Medical Industry Data Month: 2026-04 Monthly Revenue: 1,894 thousand yuan (0.02 billion) Year-on-Year Change: -65.5%

Keywords: Monthly Revenue, Biotechnology and Medical Industry

FACT BOX

Source: PR Times
Category: News
Dates in source: 2026-04

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Apr 1, 2026 9:00 AM — Distributor PR Times
Collected　May 12, 2026 8:00 AM
AI structured & analyzed　May 12, 2026 9:44 AM
Desk-reviewed & published　Apr 1, 2026 9:00 AM

FAQ

What are the key facts in this article?

Where is the primary source?

PR Times: https://openapi.twse.com.tw/revenue/twse-rev-6794-11504

When was it published?

Apr 1, 2026

Cite this article — HOW TO CITE

Washin AI News Desk“【Medigen Biotechnology】April 2026 Revenue: 0.02 Billion (Down 65.5% YoY)”AI News by Washin Village（和心村）, Apr 1, 2026. https://aeo.washinmura.jp/ai/%E5%90%91%E6%A6%AE%E7%94%9F%E6%8A%80/en/news/2026-05-12-unicocell-apr-revenue-drop

AI CRAWLER ACTIVITY

as of Jul 2, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

ClaudeBot

bot_visits_summary

4746k

last Jul 2, 2026

GPTBot

bot_visits_summary

3132k

last Jul 2, 2026

Bingbot

bot_visits_summary

1895k

last Jul 2, 2026

Google AI

bot_visits_summary

1790k

last Jul 2, 2026

Googlebot

bot_visits_summary

1307k

last Jul 2, 2026

Applebot

bot_visits_summary

734k

last Jul 2, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 向榮生技 Back to newsroom (86)

Copied